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The relationship between blood pressure and blood lead was examined in two population samples.
One ofthese consisted of 1137 men aged 49 to 65 years, the other of865 men and 856 women aged
18 to 64 years. Neither population had any known important exposure to lead, and the 95% ranges of
blood lead levels were 6 to 26 pgJlOO mL and 6 to 23 pg/mL in the men and 5 to 18 pg/100 mL in
the women.
No significant relationship between blood pressure and blood lead was detected in either of the
population samples, and the regression coefficients suggest that if there were a real effect, then the
mean difference in blood pressure per 10 pg difference in blood lead is likely to be 0.7 mm Hg in
both systolic and diastolic pressures. In the survey of 1137 men, the nrse in blood pressure was
measured during the cold pressor test. This test is likely to be affected if lead were to affect
neurogenic mediators of blood pressure. The mean change in systolic pressure was 24 mm Hg and
the 95% range was -6 to 60 mm Hg, but there was no evidence of any association with blood lead
level.
Introduction
There has been considerable interest recently in lead
as a possible determinant of blood pressure following a
report by Pirkle and his colleagues (1), who described a
positive relationship and went on to estimate the
number of deaths from cardiovascular disease that
could be attributed to lead. The evidence in the litera-
ture is, however, confusing, some studies giving evi-
dence suggestive of a positive relationship (1-3) and
others (4,5) giving no convincing evidence. We pre-
sent here data from two large cardiovascular surveys
in Wales in which data were collected on blood lead
and blood pressure.
Methods
The Caerphilly Collaborative Heart Disease Studies
(6,7) are based on a cohort of approximately 2500 men
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aged 49 to 65 years, living in Caerphilly, a small
mining town in the South Wales valleys. The data
reported here came from the first 1164 men seen in the
first follow-up examination of this cohort. A wide
range of factors of possible relevance to cardiovascular
disease, including blood lead, are being measured. The
cohort is being followed and incident cardiovascular
and other disease is being recorded.
Blood lead was measured on a sample of venous
blood from each subject using atomic absorption spec-
trophotometry. Blood pressure was measured with a
random zero muddler sphygmomanometer (8) after a
5-min rest. The rise in blood pressure during a cold
pressor test (9) was measured with an automatic
sphygmomanometer (10). In this test the hand and
wrist are immersed in water at 40C for 1 min. The
consequent rise in blood pressure has been shown to be
predictive for ischemic heart disease (11).
The Welsh Heart Programme (12,13) was a survey
throughout the Principality of Wales, completed in
1985. A stratified, cluster, random sample of 21,000
households was drawn for the main enquiry and
from this a subsample of approximately 2000 adults of
both sexes, aged 18 to 64 years, were seen for clinical
measurements. Blood pressure was measured after a
5-min rest, using a random zero muddler sphygmo-ELWOOD ETAL
manometer. Blood lead was measured as in the Caer-
philly survey, in the same laboratory.
Results
Complete data are available for 1137 men in the
Caerphilly study. The geometric mean blood lead in
this study was 12.7 ,ug/100 mL and the 95% range, after
log transformation, was 6 to 26,g/100 mL. The mean
rise in blood pressure during the cold pressor test was
24 mm Hg systolic, with a 95% range of -6 to 60 mm
Hg, and 11 mm Hg diastolic, with a 95% range of -7 to
33 mm Hg. On a logarithmic scale the pressor effect of
the testwas almost constantatall levels ofblood pressure
(mean rises of 15% systolic and 12% diastolic), and so
the results of this test are best analyzed in proportional
terms.
Data are available for 865 men and 856 women seen
in the Welsh Heart Programme. Mean blood lead
levels after log transformation are 11.6 and 9.0 ug/100
mL, and 95% ranges are 5.7 to 23.3,g/100 mL in males
and 4.5 to 18.3 g.g/100 mL in women. There is a sig-
nificant relationship with age, equivalent to a rise of
0.6 ,ug/100 mL blood lead in every decade in men and
0.8 ,ug/100 mL every decade in women.
Figure 1 displays the resting systolic blood pres-
sures, and Figure 2 displays resting diastolic pressures
in the two surveys. There is little evidence of any rela-
tionship. Table 1 shows the regression coefficients of
blood pressure on blood lead. Transformation of the
data to logarithms had little effect on the relationships
and so, to facilitate interpretation, the coefficients
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FIGuRE 2. Mean systolic blood pressure and 95% confidence intervals
(shown on only one side ofeach mean). Other details as for Fig. 1.
Table 1. Regression coefficients ofblood pressure on
blood lead in two surveys.a
Regression coefficients, ± SE
Study Sex Systolic pressure Diastolic pressure
Caerphilly M 0.077 ± 0.126 0.049 ± 0.068
Welsh Heart M 0.050 ± 0.108 0.068 ± 0.069
Programme F 0± 0.135 0.048± 0.093
aBlood pressure, mm Hg; blood lead, pg/100mL.
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FIGURE 1. Mean systolic blood pressures in the sample of 1137 men in
the Caerphilly sample and in the 1721 subjects seen in the Welsh
Heart Programme (Wales). The data for the latter study have been
standardized for sex and to a common mean age of 40 years. The
lines represent 95% confidence intervals and for clarity have been
entered on only one side.
shown are those derived from untransformed data.
None of the coefficients approaches conventional levels
of significance, and they suggest that, even if there
were a relationship, the effect of blood lead on blood
pressure would be very small. Thus, taking the larger
of the coefficients for systolic and the largest for dias-
tolic pressures, the mean rise in blood pressure per 10
,ug difference in blood lead is likely to be around 0.7
mm Hg in both systolic and diastolic pressures.
Another way of examining these data is to compare
the proportions of subjects who might be considered to
be hypertensive at various levels of blood lead. This
approach is most appropriate with the Caerphilly sub-
jects, as these are much older than the majority of the
subjects in the Welsh Heart Programme, and a sub-
stantial proportion of them have high blood pressures.
In the total cohort, 26% have systolic pressures of 160
mm Hg or greater. In the men with blood lead levels of
25 ,ug/100 mL or greater, 25% have blood pressures
above this level, and in those with blood lead levels over
30 ,ug the proportion is only 14%.
Table 2 summarizes the relationship between the rise
ofblood pressure in the cold pressor test and blood lead.
Both coefficients are very small, both are negative, and
neither is significant.
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Table 2. Regression coefficients for the rise in blood pressure
during the cold pressor test and blood lead level.
Pressure Regression coefficients ± SE
Systolic -0.071 ± 0.126
Diastolic -0.077 ± 0.065
Discussion
A number of animal studies have detected signifi-
cant increases in systolic blood pressure on exposure to
lead. Several conclusions from these are of possible
relevance to the present data. First, increases in blood
pressure appear to follow low-level lead exposures and
do not seem to occur with high levels (14). This is
relevant to the fact that, although the blood lead levels of
the subjects in the present report show a wide range,
they are all relatively low. Then, although the evidence
is not consistent, it has been suggested that an effect of
lead on blood pressure only occurs in male animals
(15). Although we do present some data for females,
most of our subjects are male. Further strengths of our
data include the fact that they are all representative
population samples drawn, in the one study, from the
whole of the Principality of Wales, and, in the other,
from a typical small Welsh town. Our subjects would
therefore appear to be well suited to test the proposed
hypothesis.
The relationships that we detect between blood
pressure and blood lead are extremely weak and are not
statistically significant. The mean difference in blood
pressure that corresponds to the 95% range observed in
blood lead in the Caerphilly sample (6-26 jug/100 mL)
is only 1.5 mm Hg systolic and 1.0 mm Hg diastolic.
Standardization of these for confounding factors, in
particular alcohol intake, but also body mass index and
cigarette consumption, would undoubtedly reduce
these figures even further.
A number of mechanisms by which lead might
affect blood pressure have been considered, but a large
number of animal studies have led to no certain con-
clusions. In a review of the evidence, Sharp et al. (16)
judged that neurogenic mediators may be involved,
leading to an alteration in vascular reactivity. If this
were true then it is not unreasonable to expect an effect
to be apparent on the cold pressor test. On the other
hand, human occupational studies (17,18) have sug-
gested that renal damage could be a mechanism in
lead-induced hypertension in workers heavily exposed
to lead, and this raises the possibility of the renin-
angiotensin axis being involved. The use of the cold
pressor response would be an inappropriate way to test
this hypothesis; however, Sharp et al. (16) judge that
renal effects are unlikely to be the primary mechanism
by which elevations in blood pressure might be
produced by lead.
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